However, a number of cancer cells are resistant to TRAIL, especially solid tumors such as glioma, pancreatic and breast [7–9] Therefore, unveiling resistance mechanisms to TRAIL-induced apoptosis, might be beneficial in finding molecules that may play critical roles in resistance process and provide opportunities to overcome TRAIL resistance. The gene discussed is TNFSF10; the disease is central nervous system cancer.